# Fresenius Kabi USA, LLC: Rifampin Injection shortage reverified (limited availability from this maker)

**Score:** 45/100

| Field | Value |
|---|---|
| Manufacturer | Fresenius Kabi USA, LLC |
| Drug | Rifampin Injection |
| Dosage form | Injection |
| Therapeutic category | Anti-Infective |
| Status | Current |
| Stage | Shortage reverified (still listed) |
| Availability | Limited availability |
| Reason | Other |
| Presentations affected | 1 |
| Package NDCs | 63323-351-20 |
| Manufacturer supply note | Check wholesalers for inventory |
| First posted | 2021-02-17 |
| Updated | 2026-10-15 |

## Why this score
- Limited availability.
- Sterile injectable: hospital and 503B demand.

Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list) (https://dps.fda.gov/drugshortages). Last refreshed: 2026-11-04T06:10:12.565Z.
From the openFDA drug shortages endpoint, which mirrors the FDA drug shortage list and can lag it by days. Availability and recovery notes are the manufacturer's own statements to FDA. Company and product level only. Verify with FDA and the manufacturer before acting.